Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 55 Records) |
| Query Trace: Disease and SLC6A3[original query] |
|---|
| SLC6A3 Polymorphism Predisposes to Dopamine Overdose in Parkinson's Disease. Frontiers in neurology 2018 9 9 693. Robertson Brian D, Al Jaja Abdullah S, MacDonald Alex A, Hiebert Nole M, Tamjeedi Ruzbeh, Seergobin Ken N, Schwarz Ute I, Kim Richard B, MacDonald Penny |
| The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms. Addiction biology 2018 Sep . Schacht Joseph P, Anton Raymond F, McNamara Patrick J, Im Yeongbin, King Andrea |
| Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society 2018 Sep . Löhle Matthias, Mangone Graziella, Wolz Martin, Beuthien-Baumann Bettina, Oehme Liane, van den Hoff Jörg, Kotzerke Jörg, Reichmann Heinz, Corvol Jean-Christophe, Storch Alexand |
| Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. The Journal of biological chemistry 2018 05 293 (19): 7250-7262. Herborg Freja, Andreassen Thorvald F, Berlin Frida, Loland Claus J, Gether Ulr |
| The influence of SLC6A3 and DRD2 polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease. The Journal of pharmacy and pharmacology 2019 Feb 71 (2): 206-212. Dos Santos Erinaldo Ubirajara Damasceno, Sampaio Tiago F, Tenório Dos Santos Aléxia D, Bezerra Leite Fernanda C, da Silva Ronaldo C, Crovella Sergio, Asano Amdore Guescel C, Asano Nadja Maria Jorge, de Souza Paulo Roberto |
| Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease. Frontiers in pharmacology 2019 10 8. Redenšek Sara, Flisar Dušan, Kojovi? Maja, Gregori? Kramberger Milica, Georgiev Dejan, Pirtošek Zvezdan, Trošt Maja, Dolžan Vi |
| Allelic variant in SLC6A3 rs393795 affects cerebral regional homogeneity and gait dysfunction in patients with Parkinson's disease. PeerJ 2019 11 7 e7957. Wang Lina, Yuan Yongsheng, Wang Jianwei, Shen Yuting, Zhi Yan, Li Junyi, Wang Min, Zhang Kezho |
| Variants in the 3' End of SLC6A3 in Northwest Han Population with Parkinson's. Parkinson's disease 2019 2019 6452471. Chang Peiye, Fu Yongwang, Zhao Ping, Wang Chunmei, Jiang Mingfang, Li Rui, He Yul |
| Association studies of dopamine synthesis and metabolism genes with multiple phenotypes of heroin dependence. BMC medical genetics 2020 Jul 21 (1): 157. Li Yunxiao, Zhu Yongsheng, Lai Jianghua, Shi Xugang, Chen Yuanyuan, Zhang Jinyu, Wei Shugua |
| Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease. The international journal of neuropsychopharmacology 2020 7 23 (8): 496-504. Redenšek Sara, Jenko Bizjan Barbara, Trošt Maja, Dolžan Vi |
| Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease. Brain and behavior 2020 Feb e01537. Micha?owska Ma?gorzata, Chalimoniuk Ma?gorzata, Jówko Ewa, Przybylska Iwona, Langfort Józef, Toczylowska Beata, Krygowska-Wajs Anna, Fiszer Urszu |
| Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease. Frontiers in neurology 2020 11 520934. Li Lanting, Lin Huixia, Hua Ping, Yan Lei, Dong Hui, Li Tan, Liu Weig |
| Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics. Medicinal research reviews 2021 6 41 (5): 2841-2886. Cacabelos Ramón, Carrera Iván, Martínez Olaia, Alejo Ramón, Fernández-Novoa Lucía, Cacabelos Pablo, Corzo Lola, Rodríguez Susana, Alcaraz Margarita, Nebril Laura, Tellado Iván, Cacabelos Natalia, Pego Rocío, Naidoo Vinogran, Carril Juan |
| Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes. Journal of Alzheimer's disease : JAD 2021 Jan . Macedo Ana, Gómez Carlos, Rebelo Miguel Ângelo, Poza Jesús, Gomes Iva, Martins Sandra, Maturana-Candelas Aarón, Pablo Víctor Gutiérrez-de, Durães Luis, Sousa Patrícia, Figueruelo Manuel, Rodríguez María, Pita Carmen, Arenas Miguel, Álvarez Luis, Hornero Roberto, Lopes Alexandra M, Pinto Nád |
| Genetic Markers as Risk Factors for the Development of Impulsive-Compulsive Behaviors in Patients with Parkinson's Disease Receiving Dopaminergic Therapy. Journal of personalized medicine 2021 12 11 (12): . Fedosova Anna, Titova Nataliya, Kokaeva Zarema, Shipilova Natalia, Katunina Elena, Klimov Euge |
| Corrigendum: The 10-Repeat 3'-UTR VNTR Polymorphism in the SLC6A3 Gene May Confer Protection Against Parkinson's Disease: A Meta-Analysis. Frontiers in genetics 2021 11 12 789112. Zeng Qiaoli, Ning Fan, Gu Shanshan, Zeng Qiaodi, Chen Riling, Peng Liuquan, Zou Dehua, Ma Guoda, Wang Yaj |
| SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population. Human genetics 2021 11 141 (1): 81-99. Mir Ali, Almudhry Montaha, Alghamdi Fouad, Albaradie Raidah, Ibrahim Mona, Aldurayhim Fatimah, Alhedaithy Abdullah, Alamr Mushari, Bawazir Maryam, Mohammad Sahar, Abdelhay Salma, Bashir Shahid, Housawi Yous |
| The dopamine transporter gene SLC6A3: multidisease risks. Molecular psychiatry 2021 10 27 (2): 1031-1046. Reith Maarten E A, Kortagere Sandhya, Wiers Corinde E, Sun Hui, Kurian Manju A, Galli Aurelio, Volkow Nora D, Lin Zhiche |
| The 10-Repeat 3'-UTR VNTR Polymorphism in the SLC6A3 Gene May Confer Protection Against Parkinson's Disease: A Meta-analysis. Frontiers in genetics 2021 12 757601. Zeng Qiaoli, Ning Fan, Gu Shanshan, Zeng Qiaodi, Chen Riling, Peng Liuquan, Zou Dehua, Ma Guoda, Wang Yaj |
| Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson's disease. Drug development research 2021 Jan . Cacabelos Ramón, Carrera Iván, Martínez Olaia, Naidoo Vinogran, Cacabelos Natalia, Aliev Gjumrakch, Carril Juan |
| Polymorphism of neurodegeneration-related genes associated with Parkinson's disease risk. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022 6 43 (9): 5301-5312. Li Jiaxin, Yi Minhan, Li Binbin, Yin Shujuan, Zhang Ying, Huang Zini, Shu Li, Zhang Yu |
| Specific dopaminergic genetic variants influence impulsivity, cognitive deficit, and disease severity of Indian ADHD probands. Molecular biology reports 2022 May . Maitra Subhamita, Chatterjee Mahasweta, Roychowdhury Anirban, Panda Chinmay Kumar, Sinha Swagata, Mukhopadhyay Kanch |
| Study of changes in rs2283265 polymorphisms in dopamine receptor D2 and rs27072 in dopamine transporter gene (SLC6A3) in patients with attention-deficit hyperactivity disorder. Iranian journal of child neurology 2022 16 (3): 121-132. Safavi Parvin, Soleimani Farsani Hossein, Farrokhi Effat, Malekpour Tehrani Afsaneh, Khoshdel Nika, Khoshdel Abolfa |
| Correlation research of susceptibility single nucleotide polymorphisms and the severity of clinical symptoms in attention deficit hyperactivity disorder. Frontiers in psychiatry 2022 10 13 1003542. Xu Yunyu, Lin Shuangxiang, Tao Jiejie, Liu Xinmiao, Zhou Ronghui, Chen Shuangli, Vyas Punit, Yang Chuang, Chen Bicheng, Qian Andan, Wang Meih |
| Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022 Jan . Soraya Gita Vita, Ulhaq Zulvikar Syambani, Shodry Syifaus, A'raaf Sirojan Kusuma Muhammad, Herawangsa Sarah, Sativa Maharani Oryza, Gustaf Aridin, Faridwazdi Dzakky Avecienna Nur, Florentia Shinta Wulandari, Raisa Neila, Bintang Andi Kurnia, Akbar Muhamm |
| The 3'UTR VNTR SLC6A3 Genetic Variant and Major Depressive Disorder: A Systematic Review. Biomedicines 2023 8 11 (8): . Bruna Rodrigues Gontijo, Isabella Possatti, Caroline Ferreira Fratelli, Alexandre Sampaio Rodrigues Pereira, Larissa Sousa Silva Bonasser, Calliandra Maria de Souza Silva, Izabel Cristina Rodrigues da Sil |
| Associations between variants in levodopa metabolic pathway genes and levodopa-induced dyskinesia in Parkinson's disease. Neuroscience letters 2023 2 801 137140. Yan Jia-Hui, Ge Yi-Lun, Wang Pu-Zhi, Li Wen, Jin Hong, Zhang Jin-Ru, Chen Jing, Wang Fen, Li Dan, Mao Cheng-Jie, Li Kai, Liu Chun-Fe |
| DAT1 and BDNF polymorphisms interact to predict A? and tau pathology. Neurobiology of aging 2023 11 133 115-124. Claire J Ciampa, Thomas M Morin, Alice Murphy, Renaud La Joie, Susan M Landau, Anne S Berry, |
| Pharmacogenetics of anxiety and depression in Alzheimer's disease. Pharmacogenomics 2023 1 24 (1): 27-57. Cacabelos Ramón, Carril Juan C, Corzo Lola, Pego Rocío, Cacabelos Natalia, Alcaraz Margarita, Muñiz Adriana, Martínez-Iglesias Olaia, Naidoo Vinogr |
| Association between the Val66Met (rs6265) polymorphism of the brain-derived neurotrophic factor (BDNF) gene, BDNF protein level in the blood and the risk of developing early?onset Parkinson's disease. Acta neurobiologiae experimentalis 2024 10 84 (3): 296-308. Iwona Przybylska, Jaros?aw Marusiak, Beata Toczy?owska, Adam St?pie?, Bogdan Brodacki, Józef Langfort, Ma?gorzata Chalimoni |
- Page last reviewed:Feb 1, 2024
- Content source: